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The intradermal injection of ouabain inhibits both secretory and ductal function in
the eccrine sweat gland. This suggests that both sodium secretion and reabsorption are
dependent on Na + K-ATPase-linked, active transport.
Ouabain-inhibitable, sodium and potassium-
activated adenosine triphosphatase (Na +
K4-ATPase) has been demonstrated in the
eccrine sweat gland (1, 2). Schulz et al. (3)
measured a decreased electrical potential across
the sweat duet after the intradermal in-
jection of ouabain (106M). Emrich and TJll-
rich (4) observed a decrease in the concen-
tration of sweat lactate, a decrease in S/P urea,
an increase in sweat sodium concentration, a de-
crease in sweat rate and an increase in osmolarity
after the intradermal injection of ouabain (1.5 X
10° to 3 x 10M). These results support the no-
tion that active cation transport occurs in both
the secretory and ductal portions of the sweat
gland. However, further studies with ouabain
seem indicated since they could clarify several
aspects of the mechanism of sodium secretion
and reabsorption by the ecerine glands. In the
human sweat gland, for example, the secretory
cells produce an isotonic fluid (3, 5). Although
it is assumed that this fluid results from the
active transport of sodium followed by the
passive diffusion of water, other mechanisms
such as filtration or anion transport have been
suggested (6, 17). If the rate of formation of
the secretory fluid could be altered by ouabain
via inhibition of Na + K-ATPase, this would
indicate that the formation of secretory fluid
depended upon active cation transport.
Since sweat collected on the skin surface is
invariably hypotonic, the composition of the
secretory fluid must be modified during its
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passage through the duct. This modification is
also thought to be the result of active sodium
transport in the duet. The "two-stage hypoth-
esis" proposes reabsorption of sodium in the
proximal duct and sodium for potassium ex-
change at a more distal duetal site (7, 8). If
these sites had differing sensitivities or varied
in their aeeessability to ouabain, it would be
possible to determine the validity of this
hypothesis.
In this study the effects of ouabain on
sweat rate and sweat sodium and potassium
concentrations were determined.
MATERIALS AND METHODS
Normal young men, aged 22 to 40, served as the
subjects of this study. No dietary restrictions were
imposed.
We first attempted to determine the optimum
concentration of ouabain as well as the optimum
interval between administration of the drug and
the time of sweating. Schulz et al. (3) had noted
that a concentration of 1 X 10-°M injected sub-
cutaneously markedly decreased the electrical po-
tential of the sweat duct and increased the sodium
concentration of the sweat in the duct. Adachi and
Yamasawa (1) used a concentration of 1 X 105M
to inhibit sweat gland Na + K-ATPase in vitro.
Based on these results, we selected an intermediate
concentration of S >< 10°M for our initial studies.
One ml of ouabain (5 X 10°M in Ringer's solu-
tion) was injected intradermally in 3 continguous
areas on one side of the upper back so that the en-
tire test site of approximately 4.5 em2 could be
treated. Ringer's solution alone was injected intra-
dermally in the contralateral side of the back. In
this and all subsequent studies, the skin of the
back was thoroughly washed and dried. Aluminum
chambers, 2.5 cm in diameter were glued to the
skin over the injected site. Thermal sweating was
induced in an environmental room (40° C ini-
tially to 46e:80% relative humidity) and sweat
collected on electrolyte-free ifiter papers (pre-
viously pre-weighed in airtight plastic vials)
within a sealed aluminum chamber. Sweat rate
was varied by gradually raising the temperature of
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the environmental room and by graded exercise.
An initial 10 minute sample was obtained followed
by 9 consecutive 5 minute samples. Immediately
after each collection period the filter papers were
returned to a pre-weighed, plastic vial and the
amount of sweat determined gravimetrically. The
filter papers were eluted with de-ionized distilled
water; sodium and potassium concentrations were
determined by flame photometry. Appropriate con-
trol studies in which known solutions of sodium
and potassium were added to ifiter papers and proc-
essed in the same way as the sweat samples indi-
cated the method was satisfactory within
The data were plotted either as electrolyte con-
centration versus sweat rate or as the rate of elec-
trolyte excretion versus sweat rate. At higher
sweat rates the rate of sodium excretion versus
sweat rate is linear, as originally proposed by
Schwartz and Thaysen (9). The slope of this line
is given as the sodium concentration of the secre-
tory fluid. The extrapolated "x" intercept of the
line is given as the maximal ductal free water
clearance.
As shown in Figure 1, when ouabain (5 X 106M)
was injected ten minutes before sweating, there
was no effect on sweat rate or the rate of sodium
excretion. Figure 2 shows the results of injecting
ouabain at various times before sweating. An effect
on sweat rate and sodium excretion could be noted
at one hour which persisted for at least 5 hours
after the injection.
Based on these preliminary results the effect of
ouabain (1 X 106M) in Ringer's solution was de-
termined in 12 normal men. Sweat collected from
a Ringer's solution injected site and an unin-
jected site served as controls.
In 3 subjects, three different concentrations of
ouabain, 1.5 X 10, 5 X l0, and 1.7 X 10 M/L,
respectively, were injected into different sites and
the results compared with sweat obtained from the
control sites.
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FIG. 1. The lack of effect of ouabain (5 X l0°
M/L) injected 10 minutes before sweating.
t 20 . M.M.
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FIG. 2. Plots of the rate of sodium excretion vs.
sweat rate. Ouabain (5 X 10°M/L) has been in-jected at various times before the sweating stim-
ulus.
RESULTs
Figure 3 depicts the rate of sodium excre-
tion plotted against sweat rate for sweat ob-
tained from the ouabain (1 x 10°M), Ringer's
solution and uninjected sites in 12 subjects.
Table I lists the derived values for sodium
concentrations of the secretory fluid, maximal
free water clearance (FWC) and mean sweat
rate for each of the three sites. The values for
maximal free water clearance are shown graph-
ically in Figure 4. In all but one subject (SL)
ouabain produced a marked reduction in FWC
compared with the control sites. In all subjects
(except All), FWC in the ouabain-injectcd
site was less than 1 ml/min/m2, whereas, those
of the control sites always exceeded 2 ml/min/
an2 (except SL). This decrease in FWC was
accompanied by a reduction in mean sweat
rate in the ouabain-injected site compared
with the two control sites which corresponded
closely (Figure 5). As shown in Table I, oua-
ham did not significantly affect the derived
sodium concentration of the secretory fluid in
10 of the 12 subjects.
Figure 6 shows plots of sweat sodium con-
centration versus sweat rate obtained after the
injection of three different dosages of oua-
ham. The uninjected sites produced results com-
parable to Ringer's solution so these data have
not been plotted. At the lowest dosage
of ouabain (1.7 x 10°M), sweat rate was un-
affected but the sodium concentration was
higher at any given sweat rate compared to
the control. At the intermediate dosage of oua-
bain (5 x 10°M), the maximum sweat rate was
approximately half the control values and
sodium concentration remained fairly constant
averaging about 130 mEq/L. When the oua-
bain concentration was increased to 1.5 x
3.0
'3
S
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Sweat rate — mi/min/m2
A. Ouabain—injected site B. Ringer's sol.— injected site
FIG. 3. Plots of the rate of sodium excretion vs. sweat rate for sweat obtained from the
ouabain-injected (5 X l0M/L) site compared with the Ringer's-injected and uninjected
control sites. Note the consistent effect of ouabain on sweat rate and "x" intercept.
TABLE I
3rF.L G.C. JR SLB'L BA
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Derived values for sodium concentration of secretory fluid, maximal free water clearance, and mean sweat
rate for ouabain-injected site (1), Ringer's solution injection site (2), and uninjected site (3)
Sodium oncentration of Secretory
fluid (mEq/L) Free-water clearance (ml/min/m2) Mean sweat rate (ml/min/m2)
Subject
FL.
G.C.
T.D.
E.V.
J.P.
S.L.
G.B.
H.H.
M.M.
A.H.
K.J.
R.C.
Mean of
2,3(I)
89
110
151
126
117
88
121
104
106
141
121
123
(2)
93
106
139
126
80
93
86
118
105
138
103
125
(3)
93
116
139
130
73
90
78
116
87
133
108
122
Mean of
1, 2, 3
92
111
143
127
90
90
95
113
99
137
111
123
(1)
.69
.50
.09
—
.20
—
.01
—
.25
.20
—
.54
—
.23
1.00
—
.07
.07
(2)
3.13
2.29
3.92
5.67
3.26
1.25
0.12
7.62
12.29
4.21
7.18
2.60
4.96
4.22
4.48
5.76
3.84
.07
8.21
3.69
14.60
4.45
12.59
2.44
4.05
3.26
4.20
5.72
3.55
.66
9.21
5.66
13.45
4.33
9.89
2.52
4.1
5.1
4.3
4.2
6.2
1.4
4.4
5.9
12.5
19.9
3.4
5.1
(2)
17.6
15.5
14.1
23.2
17.7
14.9
27.0
27.8
30.4
27.1
50.0
14.9
(3)
20.6
20.7
15 5
18.5
24.8
14.7
37.6
19.6
42.4
29.7
58.6
14.6
Meati
SE.
116 109 107 111 .10 5.30 5.76 5.54 6.3 23.4 26.4
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10-5M, only minute amounts of sweat of' con-
stant sodium content were produced. In Figure
7 the rate of sodium excretion versus sweat rate
is plotted for the same subjects. The lowest
concentration of ouabain, 1.7 x 10'M, pro-
duced a lowering of FWC. With the higher con-
centrations, 1.5 x 10 and 5 X 10'M, FWC
was abolished. The rate of potassium excretion
0
I. Ousboin-injected site
2. Ringers SQL—injected site
3. Uninjected site
I Ouabain—injected site
2 Ringer's sol.-injected site
3 Unirtjected site
FIG. 5. The effect of ouabain (5 X 1Q° M/L)
on mean sweat rate compared to the two control
sites. Ouabain produces a consistent depression in
sweat rate.
Onoboin D.lol/L)
• l5x10
x 5 x J0-
o I.7x l0
Ringer's Sal.
5 10 5 20 25 30
Sweat Rate-mi/min/m2
FIG. 6. The effect of 3 different concentrations
of ouabain on sweat sodium concentration and
sweat rate.
was increased after the injection of the highest
concentration of ouabain, 1.5 >< 10M (Figure
8). Table II and Figure 9 show potassium
concentrations at different ranges of sweat rate
after injection of the intermediate dosage of
ouabin, 5 x 10M. Potassium concentrations
were significantly increased (p < .05) at all
sweat rates.
DISCUSSION
Ouabain and related cardiac glycosides are
potent inhibitors of both active transport and
Na + K-activated ATPase in many tissues.
The striking correspondence between this en-
zyme and active transport systems and their
inhibition by cardiac glycosides is considered
to provide convincing evidence for an asso-
ciation between the two (10). Although Na +
K*_ATPase has been demonstrated in the cc-
crine sweat gland (1, 2), the details of the
mechanism of formation of precursor fluid by
the secretory cell and reabsorption of sodium
by the duct are incompletely understood. Our
data, in agreement with those of Emrich and
Ullrich (4), indicate that both sweat secretion
and sodium reabsorption are inhibited by intra-
dermally-injected ouabain. This provides evi-
dence, although indirect, that Na + K-ATP-
use-linked, active transport is involved in the
formation of precursor fluid by the secretory
x
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FIG. 4. The effect of ouabain (5 X 10_n M/L)
on maximal free-water clearance compared with
two control sites. Ouabain produces a consistent
decrease in free-water clearance indicating dimin-
ished ductal sodium reabsorption.
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FIG. 7. Plots of the rate of sodium excretion vs. sweat rate for three different doses of
ouabain. These are the same subjects as shown in Fig. 4.
cells and the reabsorption of sodium by the
duct. However, it is remotely possible that the
effects of ouabain represent non-specific toxic-
ity. For example, higher concentrations of
ouabain are capable of disturbing the ionic
balance of a cell so that it is incapable of nor-
mal function (12). This seems unlikely in our
study since the concentrations of ouabain used
varied from 1.7 x 10° to 1.5 x 1OM. These
are within the range frequently used to inhibit
active transport or Na + K-ATPase in other
tissues (11). To inhibit eccrine gland Na + K-
ATPase in vitro, Adachi and Yamasawa (1)
used 1 x 1OM ouabain and Gibbs (2) em-
ployed a concentration of 5 X 1OM. In addi-
tion, an intradermally-injected drug as in this
study, would be diluted promptly by inter-
stitial fluid and, somewhat later, by diffusion,
so that the concentration actually reaching the
target organ could be assumed to be much lower
than that originally injected.
Another effect of ouabain may be on the
nerves supplying the eccrine sweat gland. If
these were rendered functionless, then sweating
in the injected area would be eliminated or re-
duced despite a generalized thermal stimulus.
This possibility was eliminated since we failed
to observe active sweating after acetyleholine
injections in sites previously treated with oua-
bain (unpublished data). Since the acutely de-
nervated sweat gland will respond to the injec-
tion of acetyicholine, it is most unlikely that
the observed decrease in sweating after ouabain
was the result of a pharmacologic denervation
of the sweat gland. In addition, the ouabain-
injected areas showed no visible abnormalities
beyond a mild erythema localized to the area
of the injection wheal.
This evidence leads us to assume that the
inhibiting effect of ouabain on the formation
of precursor fluid and ductal sodium reab-
sorption is due to inhibition of Na + K*_
ATPase within the membranes of the sweat
gland cells. However, it is not possible to
exclude an effect on glucose or amino acid trans-
port or the inhibition of microsomal K-de-
pendent phosphatases as the underlying mech-
anism (12).
In these studies higher concentrations of
ouabain were required to inhibit the secre-
tion of sodium than its reabsorption. There
3.0
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1.0
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FIG. 8. The effect of ouabain on potassium ex-
cretion. Note the higher rate of potassium excre-
tion particularly at low sweat rates.
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The blanks show there was no sweat sample falling in that sweat rate range.
Lu
4
1-2 2-3 3-5 5-lU >10
Sweat rate -mi/min/m2
FIG. 9. The effect of ouabain on potassium ex-
cretion. Potassium concentrations were significantly
increased at all sweat rates.
seem to be several possible explanations for
this phenomenon. Assuming that ouabain
exerted its effect solely by inhibition of Na +
K*_ATPase, it may be that the secretory cells
and duct contain this enzyme whose suscepti-
bility to ouabain varies. Skou (10) has shown
that the sensitivity of Na + K*_ATPase to
ouabain differs in different tissues of the same
animal. In the eccrine sweat gland ductal and
secretory coil Na + K-ATPase have not
been studied separately, but it appears unlikely
that any enzyme from two parts of the same
organ would possess different activities. An-
other possibility is that ductal Na + K-
ATPase is more accessibIe" to ouabain than
that within the secretory cell. Ouabairi inhibits
sodium transport only when applied on the
outside of the membrane toward which sodium
is moving (10). Although the site of sodium
transport within the secretory cell has not
been localized, this cell, in common with other
TABLE II
Mean con cent ration of potassium at different sweat rates after the injection of ouabain, 5 x 1OM/L
Subject 0—! 1—2 2—3 3—5 5—10 7/0
SL 15.8 — 11.5 — 7.4 — — — — 5.7 — 4.7
FL 23.4 — 6.5 6.4 7.0 — 7.0 — 63 45 — 4,3
KJ — — 9.9 — 7.3 — 5.9 — — — — 3.3
HH — — 11.3 7.0 8.2 8.0 7.5 — 5.7 5.4 — 4.5
Ti) — — — — 5.8 — 6.9 5.0 5.0 4.4 — 3.5
wS — — — — 7.2 — 5.2 — 4.2 4.0 4.7 3.8
MC — — 6.9 — 6.4 5.4 5.4 — 5.6 4.1 4.9 4.2
MM — — — — — — 7.1 5.7 4.5 — 4 0 3.0
RC 11 2 — 10 0 — 8.4 7.1 7.4 5.6 7.3 5.6 6.6 6.1
MM — — — — 7.4 — 4.8 3.7 4.3 3.4 4.3 3.4
ST 13.5 — 10.7 7.5 7.2 — 7.6 — 5.3 4.3 — 4.3
GC — — 10.4 — 8.1 5.7 7.4 5.3 5.7 5.2 — 5.6
ST 11.2 — 7.5 57 — — — 4.6 — 4.2 — 4.1
AlT — — — — — — 6.7 7.0 — — 5.0 5.0
GB — — 11.4 — 8.5 — 8.6 — 5.8 5.2 '— 4.2jp — — — — 11.4 — 7.3 — 5.7 6.1 — 4.0
AS — — 8.0 49 — — 5.2 — 4.3 3.9 4.0 3.3
Number of 0 5 4 6 12 7
coupled
pair
Mean of
coupled
8.8 6.3 7.8 6.6 6.7 5.4 5.4 4.7 4.8 4.1
pair
— — ±0.84 ±0.41 ±0.25 ±0.34 ±0.41 ±0.36 ±0.30 ±0.18 ±0.28 ±0.40
6
4
• Ouabain 5x106 M/L
o Ringer's Sal.
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salt-secreting cells, contains numerous mito-
chondria and an elaborate system of inter-
cellular canaliculi (13) Gall bladder epithelium
has a similar structure and in this tissue the
site of active cation transport has been postu-
lated to occur near the base of the intercellular
canaliculi (14). If the same situation obtains
in the eccrine secretory cells, intradermally-
injected ouabain would have to traverse the
basal membrane, the cytoplasm and the canalic-
ular membrane of the secretory cell before it
could exert its effect on cation transport. The
movement of ouabain across membranes is
notably sluggish. It is poorly absorbed from
the intestine and, even after subcutaneous or
intramuscular injection, its absorption is ir-
regular and uncertain. After intravenous ad-
ministration, ouabain takes one-half to two
hours to produce its maximal effect on the
heart. This has been attributed to its delay in
binding to cardiac muscle (15).
If the site of sodium transport in the duct
is the basal side of the basal cell, intradermally-
injected ounbain would be readily available
to act at this locus. However, ouabain injected
ten minutes before sweating produced no ef-
fect. Ouabain exerted the same effects on sweat-
ing whether it was injected 3, 5, or 7 hours
before sweating, providing ample time for the
drug to reach the necessary site and exert its
action. Thus, it is difficult to explain the
greater inhibition of ductal function compared
with secretory function simply on the basis
of differences in location of the sodium-trans-
porting system in these portions of the sweat
gland. Further refinement in technique will be
necessary to resolve this question.
Some authors have postulated that sodium
reabsorption occurs in two stages in the cc-
crine sweat duct (7, 8). During the first
stage, occurring in the proximal duct, sodium
chloride is reabsorbed in excess of water. At a
more distant site sodium is exchanged for po-
tassium. In cystic fibrosis consistently high
sweat, sodium chloride and potassium concen-
trations have been observed. In patients with
cystic fibrosis a basic protein (Mangos factor)
has been discovered which inhibits sodium
reabsorption (16). If the Mangos factor pref-
erentially interferes with the postulated prox-
imal site, an increased sodium would be of-
fered to the distal reabsorption site increasing
its activity. The final product would be a sweat
containing increased potassium and sodium
concentrations and an even higher chloride.
In the present study potassium concentra-
tions were consistently elevated after oua-
bain administration, especially with the highest
dosage. This might be interpreted as suggesting
that the proximal sodium rea.bsorbing site, if
it exists, is more inhibited by ouabain than
the distal site. However, virtually complete
inhibition of sodium reabosorption was ob-
served with even the lowest dosage of ouabain.
If the hypothetical distal site had been func-
tioning, a lowered sodium concentration should
have been present, but such was not the case. A
more likely explanation for the increased con-
centrations of potassium would be leakage of
potassium from the ductal cells. Similar ef-
fects have been observed after digitalization in
which increased serum potassium levels have
been explained by the leakage of intracellular
potassium (17). Thus, the present study pro-
vides no evidence to support, or refute, the two-
stage reabsorption hypothesis.
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